Remote control of therapeutic T cells through a small molecule–gated chimeric receptor
暂无分享,去创建一个
Wendell A. Lim | Kole T. Roybal | W. Lim | Chia-yung Wu | J. Onuffer | James Onuffer | Elias M. Puchner | Chia-Yung Wu | E. Puchner
[1] Wendell A. Lim,et al. Counting molecules in single organelles with superresolution microscopy allows tracking of the endosome maturation trajectory , 2013, Proceedings of the National Academy of Sciences.
[2] J. Lippincott-Schwartz,et al. Imaging Intracellular Fluorescent Proteins at Nanometer Resolution , 2006, Science.
[3] L. Banaszynski,et al. Conditional control of protein function , 2006, Chemistry & biology.
[4] C. Mason,et al. Cell therapy industry: billion dollar global business with unlimited potential. , 2011, Regenerative medicine.
[5] J. Lippincott-Schwartz,et al. High-density mapping of single-molecule trajectories with photoactivated localization microscopy , 2008, Nature Methods.
[6] David L. Porter,et al. T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia , 2011, Science Translational Medicine.
[7] Michel Sadelain,et al. PD-1– and CTLA-4–Based Inhibitory Chimeric Antigen Receptors (iCARs) Divert Off-Target Immunotherapy Responses , 2013, Science Translational Medicine.
[8] S. Kim,et al. Human 4-1BB (CD137) signals are mediated by TRAF2 and activate nuclear factor-kappa B. , 1998, Biochemical and biophysical research communications.
[9] Robert DeRose,et al. Rapid and orthogonal logic gating with a gibberellin-induced dimerization system. , 2012, Nature chemical biology.
[10] A. Weiss,et al. Functional characterization of a signal transducing motif present in the T cell antigen receptor zeta chain , 1993, The Journal of experimental medicine.
[11] R. Henry,et al. Neural Stem Cell Engraftment and Myelination in the Human Brain , 2012, Science Translational Medicine.
[12] B. Kuhlman,et al. A genetically-encoded photoactivatable Rac controls the motility of living cells , 2009, Nature.
[13] A. Weiss,et al. The tyrosine phosphatase CD148 is excluded from the immunologic synapse and down-regulates prolonged T cell signaling , 2003, The Journal of cell biology.
[14] Adrian P Gee,et al. Inducible apoptosis as a safety switch for adoptive cell therapy. , 2011, The New England journal of medicine.
[15] T. Dull,et al. Targeting of human immunodeficiency virus-infected cells by CD8+ T lymphocytes armed with universal T-cell receptors , 1994 .
[16] Michel Sadelain,et al. The basic principles of chimeric antigen receptor design. , 2013, Cancer discovery.
[17] A. Ganser,et al. Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study. , 2009, The Lancet. Oncology.
[18] M. Tuszynski,et al. Long-Distance Growth and Connectivity of Neural Stem Cells after Severe Spinal Cord Injury , 2012, Cell.
[19] E. Kieff,et al. The structural basis for the recognition of diverse receptor sequences by TRAF2. , 1999, Molecular cell.
[20] Dan R. Littman,et al. Signal transduction by lymphocyte antigen receptors , 1994, Cell.
[21] Wendell A. Lim,et al. Cell-Based Therapeutics: The Next Pillar of Medicine , 2013, Science Translational Medicine.
[22] Christina D Smolke,et al. Genetic control of mammalian T-cell proliferation with synthetic RNA regulatory systems , 2010, Proceedings of the National Academy of Sciences.
[23] Stuart L. Schreiber,et al. Structure of the FKBP12-Rapamycin Complex Interacting with Binding Domain of Human FRAP , 1996, Science.
[24] Mark M Davis,et al. Continuous T cell receptor signaling required for synapse maintenance and full effector potential , 2003, Nature Immunology.
[25] L. Kane. Faculty Opinions recommendation of Distinct TCR signaling pathways drive proliferation and cytokine production in T cells. , 2013 .
[26] Yoshinori Hirano,et al. Gibberellin-induced DELLA recognition by the gibberellin receptor GID1 , 2008, Nature.
[27] Qing He,et al. Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia , 2014, Science Translational Medicine.
[28] Martin Fussenegger,et al. The use of light for engineered control and reprogramming of cellular functions. , 2012, Current opinion in biotechnology.
[29] T. Dull,et al. Targeting of human immunodeficiency virus-infected cells by CD8+ T lymphocytes armed with universal T-cell receptors. , 1994, Blood.
[30] S. Rosenberg,et al. Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[31] Bernd Hauck,et al. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. , 2013, The New England journal of medicine.
[32] P. Simms,et al. Utility of flow cytometric detection of CD69 expression as a rapid method for determining poly- and oligoclonal lymphocyte activation , 1996, Clinical and Diagnostic Laboratory Immunology.
[33] J. Bluestone,et al. Current and future immunomodulation strategies to restore tolerance in autoimmune diseases. , 2012, Cold Spring Harbor perspectives in biology.
[34] W. Wilson,et al. B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells. , 2012, Blood.
[35] S. Schreiber,et al. Proximity and orientation underlie signaling by the non‐receptor tyrosine kinase ZAP70 , 1997, The EMBO journal.
[36] M. Kalos,et al. Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology. , 2013, Immunity.
[37] S. Rosenberg,et al. Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors , 2013, Nature Reviews Clinical Oncology.
[38] Christopher A. Voigt,et al. Spatiotemporal Control of Cell Signalling Using A Light-Switchable Protein Interaction , 2009, Nature.
[39] Avijit Ray,et al. Isolation of Mouse Peritoneal Cavity Cells , 2010, Journal of visualized experiments : JoVE.
[40] Lloyd J. Old,et al. The roles of IFNγ in protection against tumor development and cancer immunoediting , 2002 .
[41] Benjamin Rhau,et al. Synthetic control of mammalian-cell motility by engineering chemotaxis to an orthogonal bioinert chemical signal , 2014, Proceedings of the National Academy of Sciences.
[42] Jared E. Toettcher,et al. Light-based feedback for controlling intracellular signaling dynamics , 2011, Nature Methods.
[43] Wendell A Lim,et al. Rewiring cell signaling: the logic and plasticity of eukaryotic protein circuitry. , 2004, Current opinion in structural biology.
[44] Jen Jen Yeh,et al. Local iontophoretic administration of cytotoxic therapies to solid tumors , 2015, Science Translational Medicine.
[45] Anthony C. Bishop,et al. Unnatural ligands for engineered proteins: new tools for chemical genetics. , 2000, Annual review of biophysics and biomolecular structure.
[46] S. Schreiber,et al. Inducible gene expression and protein translocation using nontoxic ligands identified by a mammalian three-hybrid screen. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[47] J. Sprent,et al. The role of interleukin-2 during homeostasis and activation of the immune system , 2012, Nature Reviews Immunology.
[48] Jun Wu,et al. An activating immunoreceptor complex formed by NKG2D and DAP10. , 1999, Science.
[49] K. Stankunas,et al. Rapamycin analogs with differential binding specificity permit orthogonal control of protein activity. , 2006, Chemistry & biology.
[50] Martin Fussenegger,et al. Synthetic mammalian gene circuits for biomedical applications. , 2013, Current opinion in chemical biology.
[51] Ronald D. Vale,et al. Single-Molecule Microscopy Reveals Plasma Membrane Microdomains Created by Protein-Protein Networks that Exclude or Trap Signaling Molecules in T Cells , 2005, Cell.
[52] W. Lim,et al. Integration of multiple signals through cooperative regulation of the N-WASP-Arp2/3 complex. , 2000, Science.
[53] Mark M Davis,et al. T cell killing does not require the formation of a stable mature immunological synapse , 2004, Nature Immunology.
[54] M. Konrad,et al. Engineered human tmpk/AZT as a novel enzyme/prodrug axis for suicide gene therapy. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.
[55] Marcela V Maus,et al. Antibody-modified T cells: CARs take the front seat for hematologic malignancies. , 2014, Blood.
[56] D. Campana,et al. Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[57] Jan E. Schnitzer,et al. Role of GTP Hydrolysis in Fission of Caveolae Directly from Plasma Membranes , 1996, Science.